3M is dedicated to helping facility management teams navigate the complexities of a COVID-19 world by providing the tools, products, and training to do so safely. This includes offering efficient and effective disinfectants.
The U.S. EPA* has registered the 3M™ Quat Disinfectant Cleaner Concentrate (#5), 3M™ Non-Acid Disinfectant Bathroom Cleaner Concentrate (#15), 3M™ Neutral Quat Disinfectant Cleaner Concentrate (#23), 3M™ Disinfectant RCT Cleaner Concentrate (#40), 3M™ MBS Disinfectant Cleaner Fresh Scent Concentrate (#41), 3M™ MBS Disinfectant Cleaner Concentrate (#42), 3M™ TB Quat Disinfectant Ready-To-Use Cleaner and 3M™ C. Diff Solution Tablets for the adoption of a SARS-CoV-2, the virus that causes COVID-19, efficacy claim.
These registrations are part of the EPA’s efforts to provide the public with information on how to effectively protect against the novel coronavirus on surfaces. As part of your COVID-19 preparedness and control plan, high-touch surfaces should be cleaned and disinfected regularly to help lower the risk of spreading infection. Using EPA-registered disinfectants is an important tool for reducing the risk of exposure to COVID-19.
*The U.S. EPA has started to approve disinfectants for the adoption of a SARS-CoV-2 efficacy claim. As of September 11th, the 3M™ TB Quat Disinfectant Ready-to-Use Cleaner US EPA registration #1839-83-10350) has been approved for the adoption of a SARS-CoV-2 efficacy claim, joining the 3M™ Disinfectant RCT Cleaner Concentrate (#40) (US EPA registration #6836-349-10350) and the 3M™ Quat Disinfectant Cleaner Concentrate (#5) (US EPA registration #6836-78-10350) which were approved the adoption of a SARS-CoV-2 efficacy claim on July 28, 2020. Learn more.
These approvals are part of the EPA’s efforts to provide the public with information on how to safely and effectively protect against the novel coronavirus, SARS-CoV-2 on surfaces. The EPA recently activated List N in response to the COVID-19 public health emergency that allowed manufacturers to register products with the EPA that were effective against viruses harder-to-kill than SARS-CoV-2. Currently, List N includes nine 3M™ disinfectants.
Prior to the U.S. EPA SARS-CoV-2 efficacy claim, the U.S. EPA Emerging Pathogen Policy allowed for professional judgments on effectiveness of disinfectants with current registrations with similar, representative microorganism families based on their cell structures. A person with the appropriate knowledge and technical skills to analyze such information can make a determination based on published information on disinfectant cleaners that meet the U.S. EPA Emerging Pathogen Policy for use on non-critical, hard, non-porous surfaces as defined by U.S. EPA. LIST N now includes products that meet the U.S. EPA SARS-CoV-2 efficacy claim and the U.S. EPA Emerging Pathogen Policy.
3M strongly encourages our customers to refer to all relevant regulatory bodies such as WHO, U.S. CDC and U.S. EPA for guidance on specific disinfectants during this evolving outbreak. For any country, including the U.S., local regulations should always be consulted before selecting and utilizing a disinfectant cleaner. Before reviewing the 3M product information below, please note that the general and technical information, and other statements contained in this webpage and related documents and resources, are based upon both publicly-available information and 3M-internal records, tests, or experience that 3M believes to be reliable, but the accuracy, completeness, and representative nature of such information is not guaranteed. Such information is intended for people with knowledge and technical skills sufficient to assess and apply their own informed judgment to the information. Many factors beyond 3M’s control and uniquely within user’s knowledge and control can affect the use and performance of a 3M product in a particular application. As a result, customer is solely responsible for evaluating the product and determining whether it is appropriate and suitable for customer’s application.
It is crucial to use U.S. EPA registered disinfectant solutions as they’re intended and in accordance with their label directions. Disinfectants should never be intentionally injected, ingested, inhaled, or even applied directly to the skin. 3M branded disinfectants designed for commercial use are not intended for consumer sale or use and are to be applied exclusively on non-critical hard non-porous surfaces to provide efficacy for harmful pathogens that may be present in industrial or commercial workplaces. Typical workplaces include but are not limited to hospitals, healthcare facilities and schools. There are absolutely no 3M branded disinfectants that should be intentionally injected, inhaled, or ingested or applied directly to the human skin to protect against SARS-CoV-2 (the cause of COVID-19) as these solutions are for use on non-critical hard non-porous surfaces only. 3M strongly advises our customers to use disinfecting products responsibly and in accordance with the directions on the disinfectant label. If you have any questions or concerns about using 3M disinfectant cleaners, the 3M technical team is more than willing to answer and support. In these pressing times and the heightened concerns about disinfecting and cleaning, user safety should be the forefront of these applications not only for your facilities, but yourselves. Please contact your local physician for more information on what you can do for your human body to remain healthy.
Helpful links to additional resources
Make your employees and guests/patients aware of where to go in your facility, your cleaning and disinfecting procedures, modified business hours, etc. Find a graphics manufacturer in your area to help you create signage for your facility.
3M Academy offers free, on-demand training with easy-to-follow modules covering safety information from washing hands to disinfecting for pathogens.